358 related articles for article (PubMed ID: 24936144)
21. Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis.
Waschbisch A; Atiya M; Linker RA; Potapov S; Schwab S; Derfuss T
PLoS One; 2011; 6(9):e24604. PubMed ID: 21949733
[TBL] [Abstract][Full Text] [Related]
22. Inverse correlation of expression of microRNA-140-5p with progression of multiple sclerosis and differentiation of encephalitogenic T helper type 1 cells.
Guan H; Singh UP; Rao R; Mrelashvili D; Sen S; Hao H; Zumbrun EE; Singh NP; Nagarkatti PS; Nagarkatti M
Immunology; 2016 Apr; 147(4):488-98. PubMed ID: 26780721
[TBL] [Abstract][Full Text] [Related]
23. miR-146b antagomir-treated human Tregs acquire increased GVHD inhibitory potency.
Lu Y; Hippen KL; Lemire AL; Gu J; Wang W; Ni X; Ranganathan P; Levine BL; Riley JL; June CH; Turka LA; Munn DH; Garzon R; Lu L; Blazar BR
Blood; 2016 Sep; 128(10):1424-35. PubMed ID: 27485827
[TBL] [Abstract][Full Text] [Related]
24. Investigating the Role of MicroRNA and Transcription Factor Co-regulatory Networks in Multiple Sclerosis Pathogenesis.
Nuzziello N; Vilardo L; Pelucchi P; Consiglio A; Liuni S; Trojano M; Liguori M
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463275
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-181c promotes Th17 cell differentiation and mediates experimental autoimmune encephalomyelitis.
Zhang Z; Xue Z; Liu Y; Liu H; Guo X; Li Y; Yang H; Zhang L; Da Y; Yao Z; Zhang R
Brain Behav Immun; 2018 May; 70():305-314. PubMed ID: 29545117
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA expression profile in Treg cells in the course of primary immune thrombocytopenia.
Zhu Y; Zhu H; Xie X; Zheng Z; Ling Y
J Investig Med; 2019 Dec; 67(8):1118-1124. PubMed ID: 31273052
[TBL] [Abstract][Full Text] [Related]
27. Dysregulated Network of miRNAs Involved in the Pathogenesis of Multiple Sclerosis.
Dolati S; Marofi F; Babaloo Z; Aghebati-Maleki L; Roshangar L; Ahmadi M; Rikhtegar R; Yousefi M
Biomed Pharmacother; 2018 Aug; 104():280-290. PubMed ID: 29775896
[TBL] [Abstract][Full Text] [Related]
28. Human PBMCs fight or flight response to starvation stress: Increased T-reg, FOXP3, and TGF-β1 with decreased miR-21 and Constant miR-181c levels.
Rahmani M; Mohammadnia-Afrouzi M; Nouri HR; Fattahi S; Akhavan-Niaki H; Mostafazadeh A
Biomed Pharmacother; 2018 Dec; 108():1404-1411. PubMed ID: 30453448
[TBL] [Abstract][Full Text] [Related]
29. Natalizumab Therapy Modulates miR-155, miR-26a and Proinflammatory Cytokine Expression in MS Patients.
Mameli G; Arru G; Caggiu E; Niegowska M; Leoni S; Madeddu G; Babudieri S; Sechi GP; Sechi LA
PLoS One; 2016; 11(6):e0157153. PubMed ID: 27310932
[TBL] [Abstract][Full Text] [Related]
30. Small non-coding RNA signature in multiple sclerosis patients after treatment with interferon-β.
De Felice B; Mondola P; Sasso A; Orefice G; Bresciamorra V; Vacca G; Biffali E; Borra M; Pannone R
BMC Med Genomics; 2014 May; 7():26. PubMed ID: 24885345
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-29b variants and MxA expression change during interferon beta therapy in patients with relapsing-remitting multiple sclerosis.
Fattahi M; Rezaei N; Nematalahi FS; Shaygannejad V; Fouladi S; Karimi L; Fathi F; Dehghani L; Mirmosayyeb O; Eskandari N
Mult Scler Relat Disord; 2019 Oct; 35():241-245. PubMed ID: 31421628
[TBL] [Abstract][Full Text] [Related]
32. miRNAs in cerebrospinal fluid identify patients with MS and specifically those with lipid-specific oligoclonal IgM bands.
Quintana E; Ortega FJ; Robles-Cedeño R; Villar ML; Buxó M; Mercader JM; Alvarez-Cermeño JC; Pueyo N; Perkal H; Fernández-Real JM; Ramió-Torrentà L
Mult Scler; 2017 Nov; 23(13):1716-1726. PubMed ID: 28067602
[TBL] [Abstract][Full Text] [Related]
33. Pregnancy-Induced Changes in microRNA Expression in Multiple Sclerosis.
Søndergaard HB; Airas L; Christensen JR; Nielsen BR; Börnsen L; Oturai A; Sellebjerg F
Front Immunol; 2020; 11():552101. PubMed ID: 33584638
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA profiles of MS gray matter lesions identify modulators of the synaptic protein synaptotagmin-7.
Fritsche L; Teuber-Hanselmann S; Soub D; Harnisch K; Mairinger F; Junker A
Brain Pathol; 2020 May; 30(3):524-540. PubMed ID: 31663645
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the expression of mir-34a, mir-199a, mir-30c and mir-19a in peripheral blood CD4+T lymphocytes of relapsing-remitting multiple sclerosis patients.
Ghadiri N; Emamnia N; Ganjalikhani-Hakemi M; Ghaedi K; Etemadifar M; Salehi M; Shirzad H; Nasr-Esfahani MH
Gene; 2018 Jun; 659():109-117. PubMed ID: 29551498
[TBL] [Abstract][Full Text] [Related]
36. Circulating microRNAs as biomarkers in progressive multiple sclerosis.
Vistbakka J; Elovaara I; Lehtimäki T; Hagman S
Mult Scler; 2017 Mar; 23(3):403-412. PubMed ID: 27246141
[TBL] [Abstract][Full Text] [Related]
37. Lnc-AL445665.1-4 may be involved in the development of multiple uterine leiomyoma through interacting with miR-146b-5p.
Yang E; Xue L; Li Z; Yi T
BMC Cancer; 2019 Jul; 19(1):709. PubMed ID: 31319799
[TBL] [Abstract][Full Text] [Related]
38. miRNA-Dependent CD4
Basak J; Majsterek I
Mult Scler Int; 2021; 2021():8825588. PubMed ID: 33505725
[TBL] [Abstract][Full Text] [Related]
39. miRNA contributions to pediatric-onset multiple sclerosis inferred from GWAS.
Rhead B; Shao X; Graves JS; Chitnis T; Waldman AT; Lotze T; Schreiner T; Belman A; Krupp L; Greenberg BM; Weinstock-Guttman B; Aaen G; Tillema JM; Rodriguez M; Hart J; Caillier S; Ness J; Harris Y; Rubin J; Candee MS; Gorman M; Benson L; Mar S; Kahn I; Rose J; Casper TC; Quach H; Quach D; Schaefer C; Waubant E; Barcellos LF;
Ann Clin Transl Neurol; 2019 Jun; 6(6):1053-1061. PubMed ID: 31211169
[TBL] [Abstract][Full Text] [Related]
40. Erythrocyte microRNA sequencing reveals differential expression in relapsing-remitting multiple sclerosis.
Groen K; Maltby VE; Lea RA; Sanders KA; Fink JL; Scott RJ; Tajouri L; Lechner-Scott J
BMC Med Genomics; 2018 May; 11(1):48. PubMed ID: 29783973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
